Melanotan II vs Gonadorelin
Both Melanotan II and Gonadorelin are used for sexual-health. Here's how their evidence, dosing, and regulatory status actually compare.
Melanotan II
Evidence C+Melanotan II (MT-II)
A non-selective melanocortin agonist (MC1R/MC3R/MC4R) that produces tanning and erection effects. Significant safety concerns including melanoma case reports.
View full Melanotan II profile →Gonadorelin
Evidence AGonadorelin (GnRH)
Synthetic GnRH used clinically to stimulate LH/FSH release. In testosterone replacement therapy, used pulsatile to preserve testicular size and fertility instead of hCG.
View full Gonadorelin profile →Side-by-Side
| Attribute | Melanotan II | Gonadorelin |
|---|---|---|
| Evidence Grade | C+ | A |
| FDA Status | Not FDA-approved — sold illegally as cosmetic; FDA warning letters issued | FDA-approved (Factrel) historically for diagnostic GnRH stimulation; off-label use in TRT to preserve testicular function |
| Typical Dose | 0.25–1 mg daily during loading, then maintenance (subcutaneous) | 100–500 mcg every 1–3 days (subcutaneous, pulsatile) |
| Clinics Indexed | 18 | 156 |
| Categories | skin, sexual-health | sexual-health, fertility |
Key reported benefits — Melanotan II
- ✓UV-independent tanning
- ✓Erectile effect (off-label)
Key reported benefits — Gonadorelin
- ✓LH/FSH stimulation
- ✓Testicular preservation on TRT
- ✓Fertility support
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.